Literature DB >> 15206758

Kidney and liver kynurenine pathway enzymes in chronic renal failure.

Anna Tankiewicz1, Dariusz Pawlak, Joanna Topczewska-Bruns, Wlodzimierz Buczko.   

Abstract

It has been suggested that kynurenine pathway may be an important pathological factor during the chronic renal failure (CRF) development. Therefore in the present study, in rats with end-stage of chronic renal failure, we measured the plasma and tissues (kidney and liver) concentrations of tryptophan, kynurenine, 3-hydroxykynurenine. We also evaluated the activity of tryptophan 2,3-dioxygenase in the liver (TDO), indoleamine 2,3-dioxygenase in kidney (IDO) and kynurenine 3-hydroxylase (HK) in the liver and in the kidney. The plasma and tissues tryptophan concentrations were decreased, whereas the concentrations of its metabolites increased when compared to control group. The increase in the TDO and 3-HK activity was observed, while IDO activity remains unchanged. In conclusion, the increase in the activity of TDO and HK along with disturbances of renal excreting function may be responsible for the elevation in the kynurenine and 3-hydroxykynurenine concentrations in experimental chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15206758     DOI: 10.1007/978-1-4615-0135-0_48

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

1.  Corticosteroid-regulated genes in rat kidney: mining time series array data.

Authors:  Richard R Almon; William Lai; Debra C DuBois; William J Jusko
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-06-28       Impact factor: 4.310

Review 2.  The role of placental tryptophan catabolism.

Authors:  Peter Sedlmayr; Astrid Blaschitz; Roland Stocker
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

Review 3.  Indoleamine 2,3 Dioxygenase 1-The Potential Link between the Innate Immunity and the Ischemia-Reperfusion-Induced Acute Kidney Injury?

Authors:  Anna Krupa; Mikolaj M Krupa; Krystyna Pawlak
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

4.  Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury.

Authors:  Kanishka Mohib; Shuang Wang; Qiunong Guan; Andrew L Mellor; Hongtao Sun; Caigan Du; Anthony M Jevnikar
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-14

5.  Untargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in mice.

Authors:  Qiuying Chen; Hyeong-Cheon Park; Michael S Goligorsky; Praveen Chander; Steven M Fischer; Steven S Gross
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

6.  Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis.

Authors:  Jasmohan S Bajaj; Guadalupe Garcia-Tsao; K Rajender Reddy; Jacqueline G O'Leary; Hugo E Vargas; Jennifer C Lai; Patrick S Kamath; Puneeta Tandon; Ram M Subramanian; Paul Thuluvath; Andrew Fagan; Tejasav Sehrawat; Randolph de la Rosa Rodriguez; Leroy R Thacker; Florence Wong
Journal:  Hepatology       Date:  2021-07-08       Impact factor: 17.298

7.  Indoleamine 2,3-dioxygenase overexpression causes kynurenine-modification of proteins, fiber cell apoptosis and cataract formation in the mouse lens.

Authors:  Maneesh Mailankot; Magdalena M Staniszewska; Heather Butler; Moonkyung H Caprara; Scott Howell; Benlian Wang; Catherine Doller; Lixing W Reneker; Ram H Nagaraj
Journal:  Lab Invest       Date:  2009-03-23       Impact factor: 5.662

8.  Tryptophan levels associate with incident cardiovascular disease in chronic kidney disease.

Authors:  Vetalise C Konje; Thekkelnaycke M Rajendiran; Keith Bellovich; Crystal A Gadegbeku; Debbie S Gipson; Farsad Afshinnia; Anna V Mathew
Journal:  Clin Kidney J       Date:  2020-04-12

9.  Interferon (IFN)-γ-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study.

Authors:  E M Apalset; C G Gjesdal; P M Ueland; Ø Midttun; A Ulvik; G E Eide; K Meyer; G S Tell
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

10.  Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.

Authors:  Esther Nkuipou-Kenfack; Flore Duranton; Nathalie Gayrard; Àngel Argilés; Ulrika Lundin; Klaus M Weinberger; Mohammed Dakna; Christian Delles; William Mullen; Holger Husi; Julie Klein; Thomas Koeck; Petra Zürbig; Harald Mischak
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.